Total Payments
$81,536
2024 Payments
$548.85
Companies
13
Transactions
153
Payment Breakdown by Category
Research$75,519 (92.6%)
Consulting$3,125 (3.8%)
Food & Beverage$2,867 (3.5%)
Travel$24.53 (0.0%)
Education$0.65 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $75,519 | 8 | 92.6% |
| Consulting Fee | $3,125 | 4 | 3.8% |
| Food and Beverage | $2,867 | 139 | 3.5% |
| Travel and Lodging | $24.53 | 1 | 0.0% |
| Education | $0.65 | 1 | 0.0% |
Payments by Type
Research
$75,519
8 transactions
General
$6,017
145 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Orexo US, Inc. | $79,011 | 36 | $0 (2023) |
| ABBVIE INC. | $860.09 | 47 | $0 (2024) |
| Indivior Inc. | $447.11 | 22 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $300.49 | 11 | $0 (2024) |
| Braeburn Inc. | $245.77 | 10 | $0 (2024) |
| Axsome Therapeutics, Inc. | $218.86 | 9 | $0 (2024) |
| Bausch Health US, LLC | $146.11 | 7 | $0 (2024) |
| Alkermes, Inc. | $144.68 | 6 | $0 (2023) |
| BioDelivery Sciences International, Inc. | $83.10 | 1 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.92 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $548.85 | 23 | Braeburn Inc. ($200.57) |
| 2023 | $11,368 | 35 | Orexo US, Inc. ($10,652) |
| 2022 | $60,523 | 47 | Orexo US, Inc. ($59,932) |
| 2021 | $5,355 | 25 | Orexo US, Inc. ($5,049) |
| 2020 | $27.80 | 2 | Indivior Inc. ($14.79) |
| 2019 | $165.26 | 5 | Indivior Inc. ($125.65) |
| 2018 | $3,501 | 13 | Orexo US, Inc. ($3,296) |
| 2017 | $47.35 | 3 | Orexo US, Inc. ($30.02) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/26/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Opioid Use Disorder | ||||||
| 11/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Opioid Use Disorder | ||||||
| 08/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Neuroscience | ||||||
| 08/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $113.40 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/17/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Opioid Use Disorder | ||||||
| 06/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PSYCHIATRY | ||||||
| 05/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/07/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Opioid Use Disorder | ||||||
| 05/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: PSYCHIATRY | ||||||
| 04/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/20/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Opioid Use Disorder | ||||||
| 03/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neurology | ||||||
| 02/22/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $108.35 | General |
| Category: Opioid Use Disorder | ||||||
| 02/15/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Opioid Use Disorder | ||||||
| 02/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: PSYCHIATRY | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: OUD | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OXD01-001 | Orexo US, Inc. | $75,519 | 8 |
About Dr. Aviva Zohar, MD
Dr. Aviva Zohar, MD is a Addiction Medicine healthcare provider based in Narberth, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1710109608.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aviva Zohar, MD has received a total of $81,536 in payments from pharmaceutical and medical device companies, with $548.85 received in 2024. These payments were reported across 153 transactions from 13 companies. The most common payment nature is "" ($75,519).
Ad
Practice Information
- Specialty Addiction Medicine
- Location Narberth, PA
- Active Since 05/02/2007
- Last Updated 01/24/2024
- Taxonomy Code 207QA0401X
- Entity Type Individual
- NPI Number 1710109608
Products in Payments
- Zubsolv (Drug) $3,462
- VRAYLAR (Drug) $768.70
- SUBLOCADE (Drug) $447.11
- REXULTI (Drug) $300.49
- BRIXADI (Drug) $245.77
- Auvelity (Drug) $218.86
- APLENZIN (Drug) $146.11
- VIVITROL (Drug) $95.99
- CREON (Drug) $91.39
- BELBUCA (Drug) $83.10
- Vivitrol (Drug) $48.69
- TRINTELLIX (Drug) $21.92
- SPRAVATO (Drug) $21.72
- CAPLYTA (Drug) $17.85
- Evzio (Drug) $17.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.